These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10391752)

  • 21. An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
    Finger ME; Boonen A; Woodworth TG; Escorpizo R; Christensen R; Nielsen SM; Leong AL; Scholte Voshaar M; Flurey CA; Milman N; Verstappen SM; Alten R; Guillemin F; Kloppenburg M; Beaton DE; Tugwell PS; March LM; Furst DE; Pohl C
    J Rheumatol; 2017 Nov; 44(11):1734-1739. PubMed ID: 28461648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    Lupus; 2000; 9(5):322-7. PubMed ID: 10878722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpharmacologic interventions need outcomes for evaluating complex interventions in rheumatic diseases.
    Guillemin F; Iversen MD; Rat AC; Osborne R; Petersson IF
    J Rheumatol; 2011 Aug; 38(8):1803-5. PubMed ID: 21807804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT?
    de Wit MP; Abma TA; Koelewijn-van Loon MS; Collins S; Kirwan J
    J Rheumatol; 2014 Jan; 41(1):177-84. PubMed ID: 24128777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [From uncertainty to evidence : modern statistics in rheumatology].
    Zink A; Sieper J
    Z Rheumatol; 2015 Mar; 74(2):104-5. PubMed ID: 25805511
    [No Abstract]   [Full Text] [Related]  

  • 27. A brief introduction to the National Data Bank for Rheumatic Diseases.
    Wolfe F; Michaud K
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S168-71. PubMed ID: 16273802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient outcomes in rheumatology. A review of measures.
    Association of Rheumatology Health Professionals Outcomes Measures Task Force
    Arthritis Rheum; 2003 Oct; 49(5 Suppl):S1-232. PubMed ID: 14587503
    [No Abstract]   [Full Text] [Related]  

  • 29. Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm.
    O'Neill J; Rader T; Guillemin F; Boonen A; Christensen R; Lyddiatt A; Pardo JP; Welch V; Singh JA; Tugwell P
    J Rheumatol; 2014 Jan; 41(1):150-2. PubMed ID: 24128775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updating the OMERACT filter: implications for patient-reported outcomes.
    Kirwan JR; Bartlett SJ; Beaton DE; Boers M; Bosworth A; Brooks PM; Choy E; de Wit M; Guillemin F; Hewlett S; Kvien TK; Landewé RB; Leong AL; Lyddiatt A; March L; May J; Montie PL; Nikaï E; Richards P; Voshaar MM; Smeets W; Strand V; Tugwell P; Gossec L
    J Rheumatol; 2014 May; 41(5):1011-5. PubMed ID: 24584919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment outcome parameters].
    Burmester GR; Smolen J
    Z Rheumatol; 2009 Feb; 68(1):9. PubMed ID: 19156433
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient perspective on outcomes in rheumatology -- a position paper for OMERACT 9.
    Kirwan JR; Newman S; Tugwell PS; Wells GA
    J Rheumatol; 2009 Sep; 36(9):2067-70. PubMed ID: 19738215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rheumatology in 2008. The Danish Society of Rheumatology].
    Madsen OR; Sørensen IJ; Kjaer M; Schiøttz-Christensen B; Bliddal H; Østergaard M;
    Ugeskr Laeger; 2008 Mar; 170(12):1054. PubMed ID: 18397672
    [No Abstract]   [Full Text] [Related]  

  • 34. Rheumatology in India and Pakistan today.
    Gibson T
    Rheumatology (Oxford); 2015 May; 54(5):753-4. PubMed ID: 25102860
    [No Abstract]   [Full Text] [Related]  

  • 35. Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.
    Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks P; Day R; Strand V; Wells G
    J Rheumatol; 1999 Jan; 26(1):207-9. PubMed ID: 9918265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paediatric rheumatology in India: challenges and opportunities.
    Habibi S; Aggarwal A; Ramanan AV
    Rheumatology (Oxford); 2012 Jun; 51(6):962-3. PubMed ID: 21875881
    [No Abstract]   [Full Text] [Related]  

  • 37. [Classification criteria for rheumatic diseases].
    Zeidler H
    Z Rheumatol; 2016 Aug; 75(6):616-9. PubMed ID: 27365025
    [No Abstract]   [Full Text] [Related]  

  • 38. Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures.
    Yazdany J; Myslinski R; Miller A; Francisco M; Desai S; Schmajuk G; Lacaille D; Barber CE; Orozco C; Bunyard M; Bergman MJ; Passo M; Matteson EL; Olson R; Silverman S; Warren R; Nola K; Robbins M
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1402-9. PubMed ID: 27390129
    [No Abstract]   [Full Text] [Related]  

  • 39. Disease outcomes in rheumatology.
    Scott DL; Long AF; Silman A
    Br J Rheumatol; 1995 Aug; 34(8):704-6. PubMed ID: 7551651
    [No Abstract]   [Full Text] [Related]  

  • 40. COPCORD--an unrecognized fountainhead of community rheumatology in developing countries.
    Chopra A
    J Rheumatol; 2004 Dec; 31(12):2320-2. PubMed ID: 15570627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.